PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 170 filers reported holding PHARMERICA CORP in Q1 2016. The put-call ratio across all filers is 46.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $42,090,000 | +16.5% | 1,436,519 | +4.4% | 0.05% | +13.0% |
| Q2 2017 | $36,127,000 | +24.2% | 1,376,287 | +10.7% | 0.05% | +24.3% |
| Q1 2017 | $29,085,000 | -9.9% | 1,242,948 | -3.2% | 0.04% | -11.9% |
| Q4 2016 | $32,290,000 | +212.5% | 1,283,903 | +248.8% | 0.04% | +200.0% |
| Q3 2016 | $10,333,000 | +138.0% | 368,117 | +109.1% | 0.01% | +133.3% |
| Q2 2016 | $4,341,000 | -16.0% | 176,016 | -24.7% | 0.01% | -25.0% |
| Q1 2016 | $5,166,000 | -25.4% | 233,662 | +18.1% | 0.01% | -20.0% |
| Q4 2015 | $6,924,000 | +22.9% | 197,819 | 0.0% | 0.01% | +11.1% |
| Q3 2015 | $5,632,000 | -27.2% | 197,819 | -14.8% | 0.01% | -18.2% |
| Q2 2015 | $7,732,000 | +74.1% | 232,206 | +47.4% | 0.01% | +57.1% |
| Q1 2015 | $4,440,000 | -13.5% | 157,496 | -34.0% | 0.01% | -36.4% |
| Q4 2013 | $5,131,000 | +31.3% | 238,661 | -18.9% | 0.01% | +22.2% |
| Q3 2013 | $3,907,000 | – | 294,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Smith, Graham & Co., Investment Advisors, LP | 372,169 | $8,229,000 | 1.08% |
| LOMBARDIA CAPITAL PARTNERS LLC | 839,636 | $18,564,000 | 0.96% |
| Malaga Cove Capital, LLC | 45,139 | $998,000 | 0.82% |
| Endurant Capital Management LP | 99,490 | $2,200,000 | 0.71% |
| Phocas Financial Corp. | 262,430 | $5,802,000 | 0.45% |
| Century Capital Management, LLC | 154,646 | $3,419,000 | 0.38% |
| Personal Capital Advisors Corp | 325,099 | $7,188,000 | 0.33% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 718,292 | $15,881,000 | 0.31% |
| ENDICOTT MANAGEMENT CO | 30,000 | $663,000 | 0.23% |
| Convergence Investment Partners, LLC | 70,550 | $1,560,000 | 0.19% |